SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LEXG-Lexicon Genetics -- Ignore unavailable to you. Want to Upgrade?

To: D.Lu who wrote (235)3/17/2010 12:40:47 PM
From: Arthur Radley  Read Replies (1) | Respond to of 254
 
Isn't Symphony the brainchild of the CEO...and he sits on their board? If so, it appears that this approach of using the funding is self-serving for him. I hope the funding goes into research as running three trials is an expensive task.



To: D.Lu who wrote (235)3/30/2010 4:04:45 PM
From: Arthur Radley  Respond to of 254
 
Schwab alert at the close......."Stock moved above 200 day moving average....confirmed by volume."

Some turnaround today......and volume zoomed into the close.



To: D.Lu who wrote (235)4/6/2010 3:37:14 PM
From: Arthur Radley  Respond to of 254
 
A lot of size is coming in on the bid........volume seems to be picking up. I was able to get a few shares at the $1.57 level, but then it moved away from me........sure hope they have some good news on trials at the R&D session on Thursday. Hope they didn't take the office gang to NYC to tour Radio City Music Hall. (:>)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News